...
首页> 外文期刊>Diagnostic pathology >Hyperplastic polyp or sessile serrated lesion? The contribution of serial sections to reclassification
【24h】

Hyperplastic polyp or sessile serrated lesion? The contribution of serial sections to reclassification

机译:增生息肉或无梗塞病变?序列部分重新分类的贡献

获取原文
   

获取外文期刊封面封底 >>

       

摘要

Abstract Background The histological discrimination of hyperplastic polyps from sessile serrated lesions can be difficult. Sessile serrated lesions and hyperplastic polyps are types of serrated polyps which confer different malignancy risks, and surveillance intervals, and are sometimes difficult to discriminate. Our aim was to reclassify previously diagnosed hyperplastic polyps as sessile serrated lesions or confirmed hyperplastic polyps, using additional serial sections. Methods Clinicopathological data for all colorectal hyperplastic polyps diagnosed in 2016 and 2017 was collected. The slides were reviewed and classified as hyperplastic polyps, sessile serrated lesion, or other, using current World Health Organization criteria. Eight additional serial sections were performed for the confirmed hyperplastic polyp group and reviewed. Results Of an initial 147 hyperplastic polyps from 93 patients, 9 (6.1%) were classified as sessile serrated lesions, 103 as hyperplastic polyps, and 35 as other. Of the 103 confirmed hyperplastic polyps, 7 (6.8%) were proximal, and 8 (7.8%) had a largest fragment size of ≥5?mm and??10?mm. After 8 additional serial sections, 11 (10.7%) were reclassified as sessile serrated lesions. They were all less than 5?mm and represented 14.3% of proximal polyps and 10.4% of distal polyps. An average of 3.6 serial sections were required for a change in diagnosis. Conclusion Histopathological distinction between hyperplastic polyps and sessile serrated lesions remains a challenge. This study has uncovered a potential role for the use of additional serial sections in the morphological reappraisal of small hyperplastic polyps, especially when proximally located.
机译:摘要背景陈腐病变来自无梗塞病变的增生息肉的组织学辨别。无梗塞病变和增生息肉是殖民息肉的类型,赋予不同的恶性风险,以及监测间隔,有时难以区分。我们的目的是使用额外的序列部分重新分类以前诊断出患者的增生息肉或确认的增生息肉。方法收集了2016年和2017年诊断的所有结肠直肠增生息肉的临床病理数据。使用当前的世界卫生组织标准,审查并归类为增生息肉,无术毒率息肉,无梗塞病变或其他物质。对确诊的增生息肉组进行八个额外的序列部分并进行审查。从93例患者的初始147增生息肉的结果,9(6.1%)被归类为无梗塞病变,103例为增生息肉,35次。在103个确诊的增生息肉中,7(6.8%)近端,8(7.8%)的最大片段尺寸为≥5Ω·mm,θ10≤mm。在额外的连续部分后,11(10.7%)重新分类为无梗塞病变。它们均小于5?mm,占近端息肉的14.3%,占远端息肉的10.4%。平均需要3.6个序列部分进行诊断的变化。结论增生息肉和术治疗症之间的组织病理学区分仍然是一个挑战。本研究发现在小型增生息肉的形态重述中使用额外的序列部分,特别是在近侧定位的情况下。

著录项

获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号